Compound ID | 2866
Class: Cell wall synthesis inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Moraxella catarrhalis (only bacteria it is active against); degrades Moraxella peptidoglycan |
| Description: | Antigen produced by nasal isolate of Rothia sp. |
| Institute where first reported: | University of Wisconsin-Madison, Madison, Wisconsin, USA; McMaster University, Hamilton, Ontario, Canada |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/mbio.00464-23 |